末梢性神経因性疼痛治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Peripheral Neuropathic Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Peripheral Neuropathic Pain 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Peripheral Neuropathic Pain Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Pfizer Inc. 31
Clinical Trial Overview of Pfizer Inc. 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Sumitomo Dainippon Pharma Co., Ltd. 33
Clinical Trial Overview of Sumitomo Dainippon Pharma Co., Ltd. 33
Immune Pharmaceuticals, Inc. 34
Clinical Trial Overview of Immune Pharmaceuticals, Inc. 34
GL Pharm Tech Corporation 35
Clinical Trial Overview of GL Pharm Tech Corporation 35
Endo International plc 36
Clinical Trial Overview of Endo International plc 36
E. Merck KG 37
Clinical Trial Overview of E. Merck KG 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Astellas Pharma Inc. 39
Clinical Trial Overview of Astellas Pharma Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Government Medical College Bhavnagar 40
Clinical Trial Overview of Government Medical College Bhavnagar 40
Hospital General Universitario Alicante 41
Clinical Trial Overview of Hospital General Universitario Alicante 41
University of Messina 42
Clinical Trial Overview of University of Messina 42
Shiraz University of Medical Sciences 43
Clinical Trial Overview of Shiraz University of Medical Sciences 43
University Hospital, Toulouse 44
Clinical Trial Overview of University Hospital, Toulouse 44
Sun Yat-sen University 45
Clinical Trial Overview of Sun Yat-sen University 45
Odense University Hospital 46
Clinical Trial Overview of Odense University Hospital 46
Five Key Clinical Profiles 47
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69


【レポート販売概要】

■ タイトル:末梢性神経因性疼痛治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2261CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。